Prevalence of HIV-associated opportunistic skin diseases under highly active antiretroviral therapy

被引:0
|
作者
Röcken, M
Sammet, S
Thoma-Greber, E
Crispin, A
Sakrauski, A
Prinz, J
Meurer, M
Braun-Falco, O
Plewig, G
机构
[1] Univ Munich, Munich, Germany
[2] Univ Munich, Inst IBE, Munich, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
974
引用
收藏
页码:552 / 552
页数:1
相关论文
共 50 条
  • [21] Reversal of HIV-associated motor neuron syndrome after highly active antiretroviral therapy
    M. Nishio
    K. Koizumi
    F. Moriwaka
    T. Koike
    K. Sawada
    Journal of Neurology, 2001, 248 : 233 - 234
  • [22] A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy
    Fujita, Haruyuki
    Nishikori, Momoko
    Takaori-Kondo, Akifumi
    Yoshinaga, Noriyoshi
    Ohara, Yoshiaki
    Ishikawa, Takayuki
    Haga, Hironori
    Uchiyama, Takashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (04) : 692 - 698
  • [23] HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy
    Servais, J
    Nkoghe, T
    Schmit, JC
    Arendt, V
    Robert, I
    Staub, T
    Moutschen, M
    Schneider, F
    Hemmer, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 28 (03) : 221 - 225
  • [24] A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy
    Haruyuki Fujita
    Momoko Nishikori
    Akifumi Takaori-Kondo
    Noriyoshi Yoshinaga
    Yoshiaki Ohara
    Takayuki Ishikawa
    Hironori Haga
    Takashi Uchiyama
    International Journal of Hematology, 2010, 91 : 692 - 698
  • [25] HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: An observational study
    Becker, S
    Fusco, G
    Fusco, J
    Balu, R
    Gangjee, S
    Brennan, C
    Feinberg, J
    CLINICAL INFECTIOUS DISEASES, 2004, 39 : S267 - S275
  • [26] HIV-associated wasting prevalence in the era of modern antiretroviral therapy
    Siddiqui, Javeed
    Samuel, Shanti K.
    Hayward, Brooke
    Wirka, Kelly A.
    Deering, Kathleen L.
    Harshaw, Qing
    Phillips, Amy
    Harbour, Michael
    AIDS, 2022, 36 (01) : 127 - 135
  • [27] Are the effects of isoniazid preventive therapy and highly active antiretroviral therapy additive in preventing HIV-associated tuberculosis?
    Wood, Robin
    Lawn, Stephen D.
    Bekker, Linda-Gail
    AIDS, 2009, 23 (11) : 1444 - 1446
  • [28] Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections
    Lawn, Stephen D.
    Toeroek, M. Estee
    Wood, Robin
    CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (01) : 34 - 42
  • [29] Changing Patterns in the Etiology of HIV-Associated Bacterial Pneumonia in the Era of Highly Active Antiretroviral Therapy
    E. Boumis
    N. Petrosillo
    E. Girardi
    G. De Carli
    O. Armignacco
    P. Visca
    G. Ippolito
    European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 : 71 - 73
  • [30] Long term remission of HIV-associated nephropathy (HIVAN) with highly active antiretroviral therapy (HAART).
    Ahuja, TS
    Collinge, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 755A - 755A